Product description

Insulin lispro. 
Dosage form: solution for subcutaneous and intravenous injections in 3 ml cartridges and disposable insulin pen. 

·         Widely used fast acting insulin analogue.
·         Characterised by reverse lysine and proline residues on amino acid sequence in the insulin amino acid chain. 
·         Fast absorption from subcutaneous injection sites. 
·         Onset of action after subcutaneous administration – in 15 minutes.
·         0.5-2.5 hours – maximum action. 
·         3-4 hours – duration of action.

 

Read more

Specifications

Categories Biopharmaceuticals; BiopharmaceuticalsBiosimilars
Sales markets Middle East Region (e.g. UAE); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from Russian Federation

More products from Geropharm

CAPSULE CORE COMPETENCY

CAPSULE CORE COMPETENCY

Curia - From Curiosity to Cure

Curia - From Curiosity to Cure

Alfasigma  Contract Manufacturing Showroom

Alfasigma Contract Manufacturing Showroom

Wavelength Pharmaceuticals

Wavelength Pharmaceuticals

Datwyler Pharma Packaging

Datwyler Pharma Packaging